CN209611969U - A kind of novel urethra topical remedy adjuvant treatment catheter - Google Patents
A kind of novel urethra topical remedy adjuvant treatment catheter Download PDFInfo
- Publication number
- CN209611969U CN209611969U CN201821473844.8U CN201821473844U CN209611969U CN 209611969 U CN209611969 U CN 209611969U CN 201821473844 U CN201821473844 U CN 201821473844U CN 209611969 U CN209611969 U CN 209611969U
- Authority
- CN
- China
- Prior art keywords
- urethra
- drug
- drainage channel
- channel
- air bag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The utility model discloses a kind of novel urethra topical remedies to assist in the treatment of catheter, including drainage channel tube body, and it opens in irrigation channel and air bag passage in drainage channel tube body wall, air bag passage is connected to air bag, it is characterized in that being also provided with a drug channel in the drainage channel tube body wall, there is connector in one end of the drug channel by piping connection, the other end is connected to tube screen hole body, the tube screen hole body is one section and opens in the cannulated cavity in drainage channel tube body wall, multiple sieve pores being connected to exterior space are provided on the lateral wall of the cannulated cavity.The utility model can not only be such that drug comes into full contact with urethra, and the action time of adjustable drug and urethra lesion mucous membrane, guarantee drug play maximum efficiency, also facilitate patient in the preoperative, it is postoperative and discharge after use, while can greatly reduce patient pain and repeatedly urethra operation.
Description
Technical field
The utility model relates to medical instruments, specifically a kind of to be used for urethral stricture disease conservative therapy and art
Before, the adjuvant treatment catheter of postoperative adjuvant drug.
Background technique
Ankylurethria is Urology Surgery doctor one of disease the most intractable all the time.Controlling for ankylurethria at present
Treat based on performing the operation, but Postoperative recurrent rate is always to restrict the bottleneck of its curative effect, have at present more and more researches show that, urethra
Combine relevant topical medications that can substantially reduce such as Verapamil, mitomycin after damage or ankylurethria operation
The incidence or recurrence rate of ankylurethria, used method have local application even part under irrigation of bladder/flushing, cystoscope
Injection etc., but these methods have different degrees of short slab: and irrigation of bladder or flushing, drug are mainly trapped in bladder, can not
It is come into full contact with urethra lesion portion mucous membrane, function and effect are extremely limited;Local application under neck of urinary bladder, though this method can allow drug
It is come into full contact with urethra lesion mucous membrane, but action time is limited, effect cannot be protected, and need the Cystoscopy Room in hospital
It carries out, great inconvenience has been carried out to patient, and urethra operation repeatedly is unfavorable for the reparation of patient's urethra;Locally injecting then can
Great pain is brought to patient, and effect is not better than local application under cystoscope.Generally speaking, urethra is narrow under existence conditions
Due to no good auxiliary appliance, effect is very limited for the urethra local application of narrow patient.
Utility model content
In order to overcome the problems, such as that ankylurethria patient medication cannot give full play to effect under existence conditions, this is practical new
Type provides a kind of urethra topical remedy adjuvant treatment catheter, which can not only be such that drug comes into full contact with urethra,
And the action time of adjustable drug and urethra lesion mucous membrane, guarantee drug play maximum efficiency, also facilitate patient in the preoperative,
It is postoperative and discharge after use, while can greatly reduce patient pain and repeatedly urethra operation.
The technical problem solved by the utility model is implemented by the following technical solutions:
A kind of novel urethra topical remedy adjuvant treatment catheter, including drainage channel tube body, and open in drainage channel
Irrigation channel and air bag passage in tube body wall, air bag passage are connected to the air bag for playing fixed catheter, which is characterized in that
A drug channel is also provided in the drainage channel tube body wall, there is connector in one end of the drug channel by piping connection,
The connector can be connected to the mating connection of external equipments, the other ends of drug channel such as syringes with tube screen hole body, the pipe
Shape sieve pore body is opened for one section and is provided on the cannulated cavity in drainage channel tube body wall, the lateral wall of the cannulated cavity
Multiple sieve pores being connected to exterior space.
For the utility model, the tube screen hole body is set to bulb urethrae position or the membranous part of urethra of drainage channel tube body
Position or urethra penis sponge body region.
Working principle: after drug channel is connect by connector with external equipment, the drug of external equipment can be logical by drug
Road is delivered in the cavity of tube screen hole body, then is flowed out into human urethra by the sieve pore of chamber outer wall, thus real
Now to the drug therapy of urethra.
The utility model has the advantages that the utility model can not only give full play to the effect of urethra topical remedy, it can also be according to difference
Treatment require to connect different instrument, bring great convenience to patient's treatment;Meanwhile the utility model not only can only be used to
Urethral stricture disease can also be applied to other and need the disease of localized urethral medication;The utility model can not only make medicine
Object comes into full contact with urethra, and the action time of adjustable drug and urethra lesion mucous membrane, guarantees that drug plays maximum efficiency,
Also facilitate patient in the preoperative, it is postoperative and discharge after use, while can greatly reduce patient pain and repeatedly urethra behaviour
Make.
Detailed description of the invention
Fig. 1 is the overall structure diagram of the utility model;
Fig. 2 is the enlarged partial sectional view of tube screen hole body;
Fig. 3 is A-A cross-sectional view.
In figure: 1- drainage channel tube body, 2- air bag passage, 3- irrigation channel, 4- connector, 5- drug channel, 6- tube screen
Hole body, 7- sieve pore.
Specific embodiment
Below by drawings and examples, the technical solution of the utility model is described in further detail.
Referring to shown in attached drawing 1-3, a kind of novel urethra topical remedy assists in the treatment of catheter, including drainage channel tube body 1,
And it opens in irrigation channel 3 and air bag passage 2 in drainage channel tube body wall, air bag passage and the gas for playing fixed catheter
Capsule is connected to (not shown), it is characterised in that a drug channel 5, the drug are also provided in the drainage channel tube body wall
There is connector 4 in the one end in channel by piping connection, the connector can with the mating connection of external equipments such as syringe, drug channel it is another
One end is connected to tube screen hole body 6, and the tube screen hole body is one section and opens in the cannulated chamber in drainage channel tube body wall
Body is provided with multiple sieve pores 7 being connected to exterior space on the lateral wall of the cannulated cavity.
The utility model be current two-chamber or three chambers (as shown in the picture, including drainage channel, air bag passage, rinse it is logical
Three chamber of road, two-chamber then do not include irrigation channel) on the basis of catheter, increase a drug channel and one section of tube screen hole body, it manages
Shape sieve pore body is a tiny tubular cavity, has a certain number of small sieve pores with mucous membrane of urethra contact surface, is that drug enters
The channel that urethra plays a role.The minim channel of tube screen hole body has no effect on its slickness, in order to the common portion of ankylurethria
Position matches, and can design three kinds of different tube screen hole bodies and be placed in bulb urethrae position, the membranous part of urethra, urethra corpora cavernosa penis
Cloth.Drug channel one end tube screen hole body communicates, and the other end can be connected different instruments by connector and carry out different periods
Treatment, such as directly can inject drug with syringe, micro computer infusion pump can be connected or microelectronics pump, it is required according to different treatments
It is adjusted, feasible locally injecting treatment, long-term micro continued treatment or long periods treatment.According to patient in art
Before, in art, it is postoperative and discharge after drug therapy selection be suitble to connection instrument.
The effect and working principle of each component: drainage channel drains liquid in bladder;The air bag being connected to air bag passage exists
Play fixed catheter after inflation;Irrigation channel is mainly used to bladder irrigation and perfusion;Connector can connect syringe,
Infusion apparatus, microelectronics pump etc., connect different equipment as needed;Drug channel is drug from outer into tube screen hole body
Channel;Tube screen hole body, which is used to discharge drug, to be allowed to come into full contact with mucous membrane of urethra.In simple terms, according to different treatment need
It asks, under the effect of different external connection instrument, drug enters tube screen hole body by drug channel and uniformly discharges and mucous membrane of urethra surface,
Play its effect.
During use, it such as needs to treat injection of medicine in urethra, then infuses connector and external drug
Enter equipment such as syringe to connect, drug is inputted in drug channel by infusion of medicine equipment and reaches tube screen hole body, then
It is reached in urethra by the sieve pore of tube screen hole body, urethra inner membrance is treated.
The utility model can not only give full play to the effect of urethra topical remedy, can also be required according to different treatments
Different instruments is connected, is brought great convenience to patient's treatment;Meanwhile the utility model not only can only be used to ankylurethria disease
Disease can also be applied to other and need the disease of localized urethral medication;The utility model can not only be such that drug fills with urethra
Tap touching, and the action time of adjustable drug and urethra lesion mucous membrane guarantee that drug plays maximum efficiency, also facilitate patient
In the preoperative, postoperative and discharge after use, while can greatly reduce patient pain and repeatedly urethra operation.
The advantages of basic principles and main features and the utility model of the utility model have been shown and described above.This
The technical staff of industry is not departing from the spirit of the present invention it should be appreciated that the present utility model is not limited to the above embodiments
Under the premise of range, the utility model also has various changes and improvements, these changes and improvements both fall within claimed
In range.The protection scope of the requires of the utility model is defined by the appending claims and its equivalent thereof.
Claims (2)
1. a kind of novel urethra topical remedy assists in the treatment of catheter, including drainage channel tube body, and opens in drainage channel pipe
Intraparietal irrigation channel and air bag passage, air bag passage are connected to the air bag for playing fixed catheter, which is characterized in that institute
A drug channel is also provided in the drainage channel tube body wall stated, there is connector in one end of the drug channel by piping connection, should
Connector can be connected to the mating connection of external equipment, the other end of drug channel with tube screen hole body, and the tube screen hole body is
One section open in be provided on the cannulated cavity in drainage channel tube body wall, the lateral wall of the cannulated cavity it is multiple with it is external
The sieve pore of space connection.
2. a kind of novel urethra topical remedy according to claim 1 assists in the treatment of catheter, which is characterized in that the pipe
Shape sieve pore body is set to bulb urethrae position or membranous part of urethra position or the urethra penis sponge body region of drainage channel tube body.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201821473844.8U CN209611969U (en) | 2018-09-10 | 2018-09-10 | A kind of novel urethra topical remedy adjuvant treatment catheter |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201821473844.8U CN209611969U (en) | 2018-09-10 | 2018-09-10 | A kind of novel urethra topical remedy adjuvant treatment catheter |
Publications (1)
Publication Number | Publication Date |
---|---|
CN209611969U true CN209611969U (en) | 2019-11-12 |
Family
ID=68441967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201821473844.8U Expired - Fee Related CN209611969U (en) | 2018-09-10 | 2018-09-10 | A kind of novel urethra topical remedy adjuvant treatment catheter |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN209611969U (en) |
-
2018
- 2018-09-10 CN CN201821473844.8U patent/CN209611969U/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2014012379A (en) | Devices and method for maxillary sinus lavage. | |
CN203852722U (en) | Aspiration and injection catheter apparatus with flow-limiting bladders | |
BR112019016172A2 (en) | URINARY CATHETER SYSTEM, AND METHOD FOR CLEANING THE PERIURETHRAL SPACE | |
CN2790494Y (en) | Skin soft tissue dilator | |
JP5318925B2 (en) | Urinary catheter | |
JP5373118B2 (en) | Electroliquefied prostate tissue treatment probe | |
CN104415449B (en) | Bladder irrigation anti-blocking catheter | |
CN209611969U (en) | A kind of novel urethra topical remedy adjuvant treatment catheter | |
CN112190824A (en) | Multifunctional double-balloon catheter | |
CN108066884A (en) | Ureteral catheter and its application method with sacculus | |
KR20200111026A (en) | Catheter device for reducing the pain after surgery | |
CN203244667U (en) | Dacryocyst catheter | |
CN203971142U (en) | Bladder irrigation blockage resisting catheter | |
CN106730264A (en) | A kind of porous foley's tube of two-chamber | |
CN210186225U (en) | Drainage tube and lavage device | |
CN206548973U (en) | A kind of pair of capsule multi-cavity urethral catheter | |
CN106964005A (en) | A kind of Novel dual-cavity catheter | |
CN2204172Y (en) | Prostate diffusion catheter with four cavities and three bags | |
CN2304401Y (en) | Two pocket and three chamber instrument for perfusion and drainage of prostate | |
CN212651212U (en) | Catheter with scale function | |
CN213911922U (en) | Multifunctional double-balloon catheter | |
CN213158815U (en) | Balloon urinary catheter with flushing hole | |
CN210583330U (en) | Visual prostate expands and splits ware | |
CN102772849A (en) | Balloon catheter | |
CN219001349U (en) | Novel urinary catheter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20191112 Termination date: 20200910 |
|
CF01 | Termination of patent right due to non-payment of annual fee |